<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">22469394</article-id>
      <article-id pub-id-type="pmc">3309694</article-id>
      <article-id pub-id-type="publisher-id">11-0841</article-id>
      <article-id pub-id-type="doi">10.3201/eid1804.110841</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Letter</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>Leishmania</italic> Resistance to Miltefosine Associated with Genetic Marker</article-title>
        <alt-title alt-title-type="running-head"><italic>Leishmania</italic> Resistance to Miltefosine</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Cojean</surname>
            <given-names>Sandrine</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Houz&#xE9;</surname>
            <given-names>Sandrine</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Haouchine</surname>
            <given-names>Djamel</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Huteau</surname>
            <given-names>Fran&#xE7;oise</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lariven</surname>
            <given-names>Sylvie</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hubert</surname>
            <given-names>V&#xE9;ronique</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Michard</surname>
            <given-names>Florence</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Bories</surname>
            <given-names>Christian</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Pratlong</surname>
            <given-names>Francine</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Le Bras</surname>
            <given-names>Jacques</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Loiseau</surname>
            <given-names>Philippe Marie</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Matheron</surname>
            <given-names>Sophie</given-names>
          </name>
        </contrib>
        <aff id="aff1">University of Paris-Sud, Ch&#xE2;tenay-Malabry, France (S. Cojean, F. Huteau, C. Bories, P.M. Loiseau);</aff>
        <aff id="aff2">Paris Descartes University, Paris, France (S. Houz&#xE9;, D. Haouchine, V. Hubert, J. Le Bras);</aff>
        <aff id="aff3">Paris Diderot University, Paris (S. Lariven, F. Michard, S. Matheron);</aff>
        <aff id="aff4">Montpellier University, Montpellier, France (F. Pratlong)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Sandrine Cojean, UMR 8076 CNRS BioCIS; Groupe Chimioth&#xE9;rapie Antiparasitaire; Univ Paris-Sud; 5 Rue Jean-Baptiste Cl&#xE9;ment, 92290 Ch&#xE2;tenay-Malabry, France; email: <email xlink:href="sandrine.cojean@u-psud.fr">sandrine.cojean@u-psud.fr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2012</year>
      </pub-date>
      <volume>18</volume>
      <issue>4</issue>
      <fpage>704</fpage>
      <lpage>706</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Leishmania resistance</kwd>
        <kwd>leishmaniasis</kwd>
        <kwd>miltefosine</kwd>
        <kwd>LdMT</kwd>
        <kwd>
          <italic>L. donovani</italic>
        </kwd>
        <kwd>antiretroviral</kwd>
        <kwd>parasites</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> During 2000&#x2013;2010, serial <italic>Leishmania</italic> isolates obtained from an HIV-infected patient who was not responding to treatment showed a gradual decrease in in vitro miltefosine susceptibility. We performed <italic>L. donovani</italic> miltefosine transporter (<italic>Ldmt</italic>) gene analysis to identify an association between miltefosine resistance of reference <italic>L. donovani</italic> lines and variability in miltefosine response of <italic>L. infantum</italic> isolates. A new single-nucleotide polymorphism (SNP), L832F, was identified, which might be a marker of miltefosine resistance in leishmaniasis.</p>
    <p>The patient, a 46-year-old woman, had lived in France since 1994 but regularly returned to Algeria, her country of birth. HIV-1 infection was diagnosed in 1991. Antiretroviral therapy was initiated in 1993, leading to undetectable viral load and a CD4+ T-cell count of 185 cells/mm<sup>3</sup> (reference &gt;450/mm<sup>3</sup>). Concurrent conditions were thoracic herpes zoster in 1996, hairy leukoplakia of tongue, oropharyngeal candidiasis, and chronic renal failure of unknown cause since 2000.</p>
    <p>Visceral leishmaniasis was diagnosed in 1998 by culture of a bone marrow smear, which showed intracellular amastigotes. Use of meglumine antimonate (Glucantime; Sanofi, Paris, France), a drug of choice for the treatment of leishmaniasis, was contraindicated because of pancreatitis in the patient and in vitro isolate susceptibility variation; therefore, induction therapy consisted of liposomal amphotericin B (AmpB [AmBisome; Astellas Pharma US, Deerfield, IL, USA]) at a dose of 3 mg/kg/d for 5 consecutive days, then 1&#xD7; week for 5 weeks (total dose 30 mg/kg) during 1998&#x2013;2000 (<xref ref-type="table" rid="T1">Table</xref>). The same medication was administered for relapses at 4 mg/kg/d for 5 days, then 4 mg/kg 1&#xD7; week for 5 weeks (total dose 40 mg/kg) during 2001&#x2013;2010. Given the adverse effects of AmpB and the availability of oral miltefosine (Impavido; AEterna Zentaris Inc., Quebec City, Quebec, Canada), the latter drug was used for maintenance treatment during 2001&#x2013;2007 at 50 mg 2&#xD7;/d. Leishmaniasis was monitored by leukocytoconcentration and culture of blood samples on Novy-Nicolle-McNeal medium.</p>
    <table-wrap id="T1" position="float">
      <label>Table</label>
      <caption>
        <title>Comparions of IC<sub>50</sub> for AmpB and miltefosine against promastigotes and axenic amastigotes and distribution of <italic>LdMT</italic> SNPs in <italic>Leishmania infantum</italic> isolates and reference strains*</title>
      </caption>
      <table frame="hsides" rules="groups">
        <col width="35" span="1"/>
        <col width="28" span="1"/>
        <col width="63" span="1"/>
        <col width="50" span="1"/>
        <col width="64" span="1"/>
        <col width="62" span="1"/>
        <col width="6" span="1"/>
        <col width="64" span="1"/>
        <col width="62" span="1"/>
        <col width="36" span="1"/>
        <thead>
          <tr>
            <th rowspan="3" valign="bottom" align="left" scope="col" colspan="1">Isolate</th>
            <th rowspan="3" valign="bottom" align="center" scope="col" colspan="1">Year</th>
            <th rowspan="3" valign="bottom" align="center" scope="col" colspan="1">AmpB</th>
            <th rowspan="3" valign="bottom" align="center" scope="col" colspan="1">Miltefosine</th>
            <th valign="bottom" colspan="5" align="center" scope="colgroup" rowspan="1">IC<sub>50</sub>, &#xB5;mol/L &#xB1; SEM<hr/></th>
            <th rowspan="3" valign="bottom" align="center" scope="col" colspan="1"><italic>Ldmt</italic> SNP</th>
          </tr>
          <tr>
            <th valign="bottom" colspan="2" align="center" scope="colgroup" rowspan="1">AmpB<hr/></th>
            <th valign="bottom" align="left" scope="col" rowspan="1" colspan="1">
              <hr/>
            </th>
            <th valign="bottom" colspan="2" align="center" scope="colgroup" rowspan="1">Miltefosine<hr/></th>
          </tr>
          <tr>
            <th valign="bottom" colspan="1" align="center" scope="colgroup" rowspan="1">Promastigotes</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Axenic amastigotes</th>
            <th valign="bottom" align="left" scope="col" rowspan="1" colspan="1"/>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Promastigotes</th>
            <th valign="bottom" align="center" scope="col" rowspan="1" colspan="1">Axenic amastigotes</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1998</td>
            <td valign="top" align="center" rowspan="1" colspan="1">3 mg/kg/d &#xD7; 5 d; then 1&#xD7;/wk &#xD7; 5 wk</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">S<sub>1</sub></td>
            <td valign="top" align="center" rowspan="1" colspan="1">2000</td>
            <td valign="top" align="center" rowspan="1" colspan="1">3 mg/kg/d &#xD7; 5 d; then 1&#xD7;/wk &#xD7; 5 wk</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.09 &#xB1; 0.04&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.10 &#xB1; 0.03</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">7.14 &#xB1; 0.56&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">5.00&#xB1; &#xB1; 0.7&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">L832</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2001</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4 mg/kg/d &#xD7; 5 d; then 1&#xD7;/wk &#xD7; 5 wk</td>
            <td rowspan="4" valign="top" align="center" colspan="1">50 mg 2&#xD7;/d</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">S<sub>3</sub></td>
            <td rowspan="2" valign="top" align="center" colspan="1">2005</td>
            <td rowspan="2" valign="top" align="center" colspan="1">4 mg/kg/d &#xD7; 5 d; then 1&#xD7;/wk &#xD7; 5 wk&#x2021;</td>
            <td valign="top" colspan="1" align="center" rowspan="1">0.13 &#xB1; 0.03</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.20 &#xB1; 0.03</td>
            <td rowspan="2" valign="top" align="left" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">25.93 &#xB1; 1.46&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">21.00 &#xB1; 1.50&#x2020;</td>
            <td rowspan="2" valign="top" align="center" colspan="1">832<sub>L</sub>/F</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">S<sub>4</sub></td>
            <td valign="top" colspan="1" align="center" rowspan="1">0.24 &#xB1; 0.01&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.15 &#xB1; 0.02</td>
            <td valign="top" colspan="1" align="center" rowspan="1">27.89 &#xB1; 1.76&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">31.90 &#xB1; 1.60&#x2020;</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">2007</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4 mg/kg/d &#xD7; 5 d; then 1&#xD7;/wk &#xD7; 5 wk</td>
            <td valign="top" colspan="1" align="center" rowspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">S<sub>6</sub></td>
            <td valign="top" align="center" rowspan="1" colspan="1">2008</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4 mg/kg/d &#xD7; 5 d; then 1&#xD7;/wk &#xD7; 5 wk</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.16 &#xB1; 0.03</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.11 &#xB1; 0.03</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">44.30 &#xB1; 3.70&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">50.10 &#xB1; 1.00&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">832F</td>
          </tr>
          <tr>
            <td valign="top" align="left" scope="row" rowspan="1" colspan="1">S<sub>7</sub></td>
            <td valign="top" align="center" rowspan="1" colspan="1">2010</td>
            <td valign="top" align="center" rowspan="1" colspan="1">4 mg/kg/d &#xD7; 5 d; then 1&#xD7;/wk &#xD7; 5 wk</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">&#x2013;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">L832</td>
          </tr>
          <tr>
            <td colspan="2" valign="top" align="left" scope="col" rowspan="1">Reference strain</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> LV9 WT</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">0.03 &#xB1; 0.02</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.02 &#xB1; 0.05</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">4.46 &#xB1; 0.29&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">6.20 &#xB1; 0.3</td>
            <td valign="top" align="center" rowspan="1" colspan="1">L832</td>
          </tr>
          <tr>
            <td colspan="3" valign="top" align="left" scope="row" rowspan="1"> LV9 Miltefosine-R</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">0.22 &#xB1; 0.04</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.70 &#xB1; 0.09</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">45.84 &#xB1; 2.40&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">54.20 &#xB1; 2.20&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">832F</td>
          </tr>
          <tr>
            <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> DD8 WT</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">0.06 &#xB1; 0.02&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">0.05 &#xB1; 0.03&#x2020;</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">17.40 &#xB1; 1.70</td>
            <td valign="top" align="center" rowspan="1" colspan="1">12.40 &#xB1; 1.50</td>
            <td valign="top" align="center" rowspan="1" colspan="1">L832</td>
          </tr>
          <tr>
            <td colspan="2" valign="top" align="left" scope="row" rowspan="1"> DD8 AmpB-R</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">1.42 &#xB1; 0.06&#x2020;</td>
            <td valign="top" align="center" rowspan="1" colspan="1">1.00 &#xB1; 0.07&#x2020;</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="center" rowspan="1" colspan="1">15.20 &#xB1; 1.00</td>
            <td valign="top" align="center" rowspan="1" colspan="1">10.30 &#xB1; 1.20</td>
            <td valign="top" align="center" rowspan="1" colspan="1">L832</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <p>*IC<sub>50</sub>, 50% inhibitory concentration; AmpB, amphotericin B; <italic>Ldmt</italic>, <italic>Leishmania donovani</italic> miltefosine transporter gene; SNP, single-nucleotide polymorphism; &#x2013;, assay not performed because sample unavailable or not culturable; WT, wild type; R, resistant.&#x2028;&#x2020;Significance was analyzed by using the nonparametric Mann-Whitney U test to compare the IC<sub>50</sub> of the isolates with the IC<sub>50</sub> of reference strains; p&lt;0.01 was considered significant. IC<sub>50</sub> of AmpB and miltefosine was compared with IC<sub>50</sub> of reference strains and S<sub>1</sub>/S<sub>3</sub>, S<sub>1</sub>/S<sub>4</sub>, and S<sub>1</sub>/S<sub>6</sub>. Miltefosine: S<sub>1</sub>/S<sub>3</sub>, S<sub>1</sub>/S<sub>4</sub>, S<sub>1</sub>/S<sub>6</sub>, S<sub>4</sub>/S<sub>6</sub>; p&lt;0.01. AmpB: S<sub>1</sub>/S<sub>4</sub> significant p&lt;0.01; S<sub>1</sub>/S<sub>3</sub>, S<sub>1</sub>/S<sub>6</sub> not significant.&#x2028;&#x2021;For each relapse.</p>
      </table-wrap-foot>
    </table-wrap>
    <p>When signs of biological and clinical relapse appeared, bone marrow was aspirated for parasite detection. After culture of the aspirate and isoenzyme determination, the strain was identified as <italic>L. infantum</italic>, zymodeme MON-24. Eleven relapses were documented; all were confirmed by positive direct examination of bone marrow or blood, but cultures of only 7 samples yielded positive results (<xref ref-type="table" rid="T1">Table</xref>).</p>
    <p>The susceptibility of 4 cryopreserved isolates (S<sub>1</sub>, S<sub>3</sub>, S<sub>4</sub>, and S<sub>6</sub>; Table) to AmpB and to miltefosine was studied in the in vitro promastigote and axenic amastigote form by determining the concentrations inhibiting parasite growth by 50% (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>,<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). The 50% inhibitory concentration (IC<sub>50</sub>) was determined in parallel for the following reference <italic>L. donovani</italic> lines: a wild-type <italic>L. donovani</italic> LV9 (MHOM/ET/67/HU3) line (LV9 WT), a wild-type <italic>L. donovani</italic> DD8 (MHOM/IN/80/DD8) line (DD8 WT), a laboratory miltefosine-resistant line obtained from LV9 WT (LV9 miltefosine-R, resistant to 90 &#x3BC;mol/L miltefosine), and the laboratory AmB-resistant line obtained from DD8 WT (DD8 AmB-R, resistant to 1.4 &#x3BC;mol/L AmB) on promastigote and axenic amastigote forms (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>,<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>).</p>
    <p>The AmB susceptibility of the isolates did not change notably over time; IC<sub>50</sub> values ranged from 0.09 &#xB5;mol/L to 0.24 &#xB5;mol/L, regardless of parasite form, similar to those of wild-type reference strains (<xref ref-type="table" rid="T1">Table</xref>). In contrast, the IC<sub>50</sub> values of miltefosine increased greatly over time, from 5.00 &#xB5;mol/L to 50.10 &#x3BC;mol/L. During the 6 years of follow-up with miltefosine maintenance therapy, the susceptibility of the isolate (S<sub>6</sub>) obtained 6 months after miltefosine treatment withdrawal in 2008 was 6-fold higher than that of the first isolate (S<sub>1</sub>) obtained in 2000.</p>
    <p>The <italic>L. donovani</italic> miltefosine transporter protein (LdMT) promotes miltefosine translocation (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>), and LdMT inactivation in <italic>L. donovani</italic> promastigotes leads to miltefosine resistance at the promastigote and amastigote stages (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>). In 2003 and 2006 studies, several mutations were linked to the inability of parasites to take up miltefosine and to miltefosine resistance (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>,<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>). In a 2009 study, the weak expression of LdMT and its &#x3B2; subunit LdROS3 in <italic>L. braziliensis</italic> isolates was linked to diminished sensitivity (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>). We sequenced the entire <italic>Ldmt</italic> gene (3,294 bp) in the reference strains and the clinical isolates for SNP analysis (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>,<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>). Only 1 new SNP, L832F, was found in the miltefosine-resistant reference strain (LV9 miltefosine-R) and in clinical isolate S<sub>6</sub>. The L832 wild-type allele was found in isolate S<sub>1</sub> and in the miltefosine-sensitive reference lines (LV9, DD8, and DD8 AmpB-R), whereas both alleles were found in isolates S<sub>3</sub> and S<sub>4</sub>, with a decrease in the wild-type allele (<xref ref-type="table" rid="T1">Table</xref>). The last isolate, which was obtained 3 years after miltefosine withdrawal and could not be subcultured, had reverted to the wild-type allele (L832).</p>
    <p>These results point to a relation between the 832F allele and diminished susceptibility to miltefosine. Analysis of this case of miltefosine resistance in a patient co-infected with <italic>Leishmania</italic> sp. and HIV strongly suggests that an SNP (L832F) in the <italic>Ldmt</italic> gene could represent a molecular marker of miltefosine resistance in <italic>L. infantum</italic> and <italic>L. donovani</italic>.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Cojean S, Houz&#xE9; S, Haouchine D, Huteau F, Lariven S, Hubert V, et al. <italic>Leishmania</italic> resistance to miltefosine related to genetic marker [letter]. Emerg Infect Dis [serial on the Internet]. 2012 Apr [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1804.110841">http://dx.doi.org/10.3201/eid1804.110841</ext-link></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Vieira</surname>
<given-names>NC</given-names></string-name>, <string-name><surname>Herrenknecht</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Vacus</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fournet</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bories</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Figad&#xE8;re</surname>
<given-names>B</given-names></string-name>, <etal/>
<article-title>Selection of the most promising 2-substituted quinoline as antileishmanial candidate for clinical trials.</article-title>
<source>Biomed Pharmacother</source>. <year>2008</year>;<volume>62</volume>:<fpage>684</fpage>&#x2013;<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1016/j.biopha.2008.09.002</pub-id><pub-id pub-id-type="pmid">18849137</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Vermeersch</surname>
<given-names>M</given-names></string-name>, <string-name><surname>da Luz</surname>
<given-names>RI</given-names></string-name>, <string-name><surname>Tot&#xE9;</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Timmermans</surname>
<given-names>JP</given-names></string-name>, <string-name><surname>Cos</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Maes</surname>
<given-names>L</given-names></string-name>. <article-title>In vitro susceptibilities of <italic>Leishmania donovani</italic> promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2009</year>;<volume>53</volume>:<fpage>3855</fpage>&#x2013;<lpage>9</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.00548-09</pub-id><pub-id pub-id-type="pmid">19546361</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Mbongo</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Loiseau</surname>
<given-names>PM</given-names></string-name>, <string-name><surname>Billion</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Robert-Gero</surname>
<given-names>M</given-names></string-name>. <article-title>Mechanism of amphotericin B resistance in <italic>Leishmania donovani</italic> promastigotes.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>1998</year>;<volume>42</volume>:<fpage>352</fpage>&#x2013;<lpage>7</lpage><pub-id pub-id-type="pmid">9527785</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Seifert</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Matu</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Perez-Victoria</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Castanys</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gamarro</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Croft</surname>
<given-names>SL</given-names></string-name>. <article-title>Characterisation of <italic>Leishmania donovani</italic> promastigotes resistant to hexadecylphosphocholine (miltefosine).</article-title>
<source>Int J Antimicrob Agents</source>. <year>2003</year>;<volume>22</volume>:<fpage>380</fpage>&#x2013;<lpage>7</lpage>
<pub-id pub-id-type="doi">10.1016/S0924-8579(03)00125-0</pub-id><pub-id pub-id-type="pmid">14522101</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Perez-Victoria</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>Gamarro</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Ouellette</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Castanys</surname>
<given-names>S</given-names></string-name>. <article-title>Functional cloning of the miltefosine transporter. A novel P-type phospholipid translocase from <italic>Leishmania</italic> involved in drug resistance.</article-title>
<source>J Biol Chem</source>. <year>2003</year>;<volume>278</volume>:<fpage>49965</fpage>&#x2013;<lpage>71</lpage>
<pub-id pub-id-type="doi">10.1074/jbc.M308352200</pub-id><pub-id pub-id-type="pmid">14514670</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Seifert</surname>
<given-names>K</given-names></string-name>, <string-name><surname>P&#xE9;rez-Victoria</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>Stettler</surname>
<given-names>M</given-names></string-name>, <string-name><surname>S&#xE1;nchez-Ca&#xF1;ete</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Castanys</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Gamarro</surname>
<given-names>F</given-names></string-name>, <etal/>
<article-title>Inactivation of the miltefosine transporter, LdMT, causes miltefosine resistance that is conferred to the amastigote stage <italic>of Leishmania donovani</italic> and persists in vivo.</article-title>
<source>Int J Antimicrob Agents</source>. <year>2007</year>;<volume>30</volume>:<fpage>229</fpage>&#x2013;<lpage>35</lpage>
<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2007.05.007</pub-id><pub-id pub-id-type="pmid">17628445</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>P&#xE9;rez-Victoria</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>S&#xE1;nchez-Ca&#xF1;ete</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Seifert</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Croft</surname>
<given-names>SL</given-names></string-name>, <string-name><surname>Sundar</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Castanys</surname>
<given-names>S</given-names></string-name>, <etal/>
<article-title>Mechanisms of experimental resistance of <italic>Leishmania</italic> to miltefosine: implications for clinical use.</article-title>
<source>Drug Resist Updat</source>. <year>2006</year>;<volume>9</volume>:<fpage>26</fpage>&#x2013;<lpage>39</lpage>
<pub-id pub-id-type="doi">10.1016/j.drup.2006.04.001</pub-id><pub-id pub-id-type="pmid">16814199</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>S&#xE1;nchez-Ca&#xF1;ete</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Carvalho</surname>
<given-names>L</given-names></string-name>, <string-name><surname>P&#xE9;rez-Victoria</surname>
<given-names>FJ</given-names></string-name>, <string-name><surname>Gamarro</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Castanys</surname>
<given-names>S</given-names></string-name>. <article-title>Low plasma membrane expression of the miltefosine transport complex renders <italic>Leishmania braziliensis</italic> refractory to the drug.</article-title>
<source>Antimicrob Agents Chemother</source>. <year>2009</year>;<volume>53</volume>:<fpage>1305</fpage>&#x2013;<lpage>13</lpage>
<pub-id pub-id-type="doi">10.1128/AAC.01694-08</pub-id><pub-id pub-id-type="pmid">19188379</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
